473 related articles for article (PubMed ID: 30678453)
41. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
[TBL] [Abstract][Full Text] [Related]
42. Transcatheter Arterial Chemoembolization Combined with Simultaneous Cone-beam Computed Tomography-guided Microwave Ablation in the Treatment of Small Hepatocellular Carcinoma: Clinical Experiences From 50 Procedures.
Li Z; Hao D; Jiao D; Zhang W; Han X
Acad Radiol; 2021 Nov; 28 Suppl 1():S64-S70. PubMed ID: 33060007
[TBL] [Abstract][Full Text] [Related]
43. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
44. Ultrasound-guided percutaneous microwave ablation of sporadic renal angiomyolipoma: preliminary results.
Han ZY; Liang P; Yu XL; Cheng ZG; Liu FY; Yu J
Acta Radiol; 2015 Jan; 56(1):56-62. PubMed ID: 24526757
[TBL] [Abstract][Full Text] [Related]
45. Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions : New advances in interventional oncology: state of the art.
De Cobelli F; Marra P; Ratti F; Ambrosi A; Colombo M; Damascelli A; Sallemi C; Gusmini S; Salvioni M; Diana P; Cipriani F; Venturini M; Aldrighetti L; Del Maschio A
Med Oncol; 2017 Apr; 34(4):49. PubMed ID: 28220346
[TBL] [Abstract][Full Text] [Related]
46. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
Izzo F; Granata V; Grassi R; Fusco R; Palaia R; Delrio P; Carrafiello G; Azoulay D; Petrillo A; Curley SA
Oncologist; 2019 Oct; 24(10):e990-e1005. PubMed ID: 31217342
[TBL] [Abstract][Full Text] [Related]
47. Microwave ablation combined with attenuated Salmonella typhimurium for treating hepatocellular carcinoma in a rat model.
Zhao Q; Qu X; Liu K; Shi H; Yang G; Zhou B; Zhu L; Zhang W; Yan Z; Liu R; Qian S; Wang J
Oncotarget; 2017 Jul; 8(29):47655-47664. PubMed ID: 28498813
[TBL] [Abstract][Full Text] [Related]
48. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
Long J; Zheng JS; Sun B; Lu N
Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
[TBL] [Abstract][Full Text] [Related]
49. Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes.
Liu K; Zheng H; Sui X; Liu B; Meng M; Feng Y; Zhu Q; Zhao X
Eur Radiol; 2023 Mar; 33(3):1938-1948. PubMed ID: 36114849
[TBL] [Abstract][Full Text] [Related]
50. A clinical study of thermal monitoring techniques of ultrasound-guided microwave ablation for hepatocellular carcinoma in high-risk locations.
Zhi-Yu H; Ping L; Xiao-Ling Y; Zhi-Gang C; Fang-Yi L; Jie Y
Sci Rep; 2017 Jan; 7():41246. PubMed ID: 28112263
[TBL] [Abstract][Full Text] [Related]
51. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Facciorusso A; Di Maso M; Muscatiello N
Int J Hyperthermia; 2016 May; 32(3):339-44. PubMed ID: 26794414
[TBL] [Abstract][Full Text] [Related]
52. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques.
Ding J; Jing X; Liu J; Wang Y; Wang F; Wang Y; Du Z
Clin Radiol; 2013 Jun; 68(6):608-15. PubMed ID: 23399463
[TBL] [Abstract][Full Text] [Related]
53. Microwave ablation of hepatocellular carcinoma as first-line treatment: long term outcomes and prognostic factors in 221 patients.
Wang T; Lu XJ; Chi JC; Ding M; Zhang Y; Tang XY; Li P; Zhang L; Zhang XY; Zhai B
Sci Rep; 2016 Sep; 6():32728. PubMed ID: 27620527
[TBL] [Abstract][Full Text] [Related]
54. Different power modes of microwave ablation for hepatocellular carcinoma: Evaluation of recurrence rate and factors related to recurrence.
Dong T; Nie F; Liu T; Wang L; Yang D; Yan X
Asian J Surg; 2023 Sep; 46(9):3520-3528. PubMed ID: 37002048
[TBL] [Abstract][Full Text] [Related]
55. Multiparametric magnetic resonance-guided and monitored microwave ablation in liver cancer.
Zhang K; Liu M; Xu Y; He X; Sequeiros RB; Li C
J Cancer Res Ther; 2020; 16(7):1625-1633. PubMed ID: 33565509
[TBL] [Abstract][Full Text] [Related]
56. Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progression.
McDevitt JL; Collard MD; Murphy RP; Sutphin PD; Yopp AC; Singal AG; Kalva SP
Clin Imaging; 2020 Nov; 67():146-151. PubMed ID: 32659600
[TBL] [Abstract][Full Text] [Related]
57. Microwave ablation of large HCC lesions: Added value of CEUS examinations for ablation success control.
Pregler B; Beyer LP; Wiesinger I; Nießen C; Jung EM; Stroszczynski C; Wiggermann P
Clin Hemorheol Microcirc; 2016; 64(3):483-490. PubMed ID: 27935548
[TBL] [Abstract][Full Text] [Related]
58. Computed tomography-guided percutaneous cryoablation and microwave ablation in the treatment of perivascular hepatocellular carcinoma: A comparative study with propensity score matching.
Li B; Ren ZW; Zhang C; Yu XX; Xu XX; Du Y; Yang HF
Clin Res Hepatol Gastroenterol; 2024 Mar; 48(3):102298. PubMed ID: 38367802
[TBL] [Abstract][Full Text] [Related]
59. Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation.
Sun AX; Cheng ZL; Wu PP; Sheng YH; Qu XJ; Lu W; Zhao CG; Qian GJ
World J Gastroenterol; 2015 Mar; 21(10):2997-3004. PubMed ID: 25780298
[TBL] [Abstract][Full Text] [Related]
60. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB
Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
